Benzinga | Aug 5, 2021 08:03AM EDT

Arbutus Biopharma Q2 EPS $(0.23) Misses $(0.22) Estimate, Sales $2.33M Beat $2.12M Estimate

Arbutus Biopharma (NASDAQ:ABUS) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.22) by 4.55 percent. This is a 8 percent increase over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $2.33 million which beat the analyst consensus estimate of $2.12 million by 9.86 percent. This is a 53.83 percent increase over sales of $1.51 million the same period last year.